发明名称 Ergoline derivatives and their use as somatostatin receptor antagonists
摘要 The compound of formula I in free base or acid addition salt form where: R1 is hydrogen, (C1-4)alkyl or a group of formula (a) where n is 1 to 4 and R7 is fluorine, chlorine, hydroxy, (C1-4)alkyl or (C1-4)alkoxy. R2 is hydrogen, chlorine, bromine, iodine, (C1-4)alkyl or (C1-4)alkylthio. R3 is hydrogen or (C1-4)alkyl, R4 is a group of formula (c) or (d) where R8 is fluorine, chlorine, nitro or cyano and R11 is (C1-4)alkyl or (C2-5)alkenyl or a group of formula (e) or (f) where X are independently O or S. R5 and R6 are each hydrogen or form together a further bond between the two carbon atoms on which they are located. Also described are pharmaceutical compositions comprising the compound of formula I. The compounds of formula I are useful for the treatment of depression, anxiety, bipolar disorder and ADHD.
申请公布号 NZ500386(A) 申请公布日期 2002.05.31
申请号 NZ19980500386 申请日期 1998.05.27
申请人 NOVARTIS AG 发明人 STUTZ, PETER;PFAEFFLI, PAUL;NEUMANN, PETER;SWOBODA, ROBERT
分类号 A61K31/48;A61K31/496;A61P25/00;A61P25/22;A61P25/24;A61P25/28;A61P43/00;C07D457/08;C07D519/00;(IPC1-7):C07D457/08 主分类号 A61K31/48
代理机构 代理人
主权项
地址